Impact of the COVID-19 Epidemic on Glycemic Balance and the Level of Stress in Diabetic Patients (NCT04924673) | Clinical Trial Compass
CompletedNot Applicable
Impact of the COVID-19 Epidemic on Glycemic Balance and the Level of Stress in Diabetic Patients
France202 participantsStarted 2020-06-17
Plain-language summary
Prospective, non-interventional, multicentric study
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patient (≥ 18 years old)
* Diabetic patient (type 1 or type 2) regardless of their diabetes treatment who experienced complete confinement in their own home, in France.
* Patients who had a measured HbA1 or an estimated HbA1c with a glucose sensor Freestyle libre with a known result, between November 1, 2019 and February 29, 2020.
* Patients agreeing to have their HbA1c measured between May 15 and July 31, 2020.
* Having been informed of the study and not objecting to participating in it
Exclusion Criteria:
\- Adults over the age of legal protection (safeguard of justice, curatorship, guardianship), persons deprived of their liberty.